We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$445M
AUM Growth
+$6.22M
Cap. Flow
+$4.93M
Cap. Flow %
1.11%
Top 10 Hldgs %
17.39%
Holding
285
New
23
Increased
106
Reduced
62
Closed
22

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$2.81M
2
RTX icon
RTX Corp
RTX
+$2.68M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$1.79M
4
PH icon
Parker-Hannifin
PH
+$1.6M
5
KLAC icon
KLA
KLAC
+$1.21M

Top Sells

Rank Stock Value
1
KS
KapStone Paper and Pack Corp.
KS
+$4.63M
2
MO icon
Altria Group
MO
+$2.29M
3
PG icon
Procter & Gamble
PG
+$2.11M
4
PM icon
Philip Morris
PM
+$1.94M
5
MON
Monsanto Co
MON
+$1.32M

Sector Composition

Rank Sector Weight
1 Industrials 17.84%
2 Healthcare 15.87%
3 Technology 15.47%
4 Materials 7.53%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARRY
126
DELISTED
Array Biopharma Inc
ARRY
$876K 0.2%
+52,187
New +$830K
SBUX icon
127
Starbucks
SBUX
$119B
$873K 0.2%
17,864
+1,754
+11% +$99.5K
BCC icon
128
Boise Cascade
BCC
$2.69B
$871K 0.2%
19,487
+2,717
+16% +$119K
ORCL icon
129
Oracle
ORCL
$352B
$868K 0.2%
19,696
+1,945
+11% +$89.6K
MTB icon
130
M&T Bank
MTB
$36B
$862K 0.19%
5,064
+597
+13% +$107K
PFBC icon
131
Preferred Bank
PFBC
$1.27B
$847K 0.19%
13,782
+2,260
+20% +$146K
PSX icon
132
Phillips 66
PSX
$84B
$847K 0.19%
7,541
-70
-0.9% -$7.87K
AMGN icon
133
Amgen
AMGN
$197B
$836K 0.19%
4,527
+542
+14% +$95.9K
ASIX icon
134
AdvanSix
ASIX
$554M
$827K 0.19%
22,577
+3,118
+16% +$117K
CELG
135
DELISTED
Celgene Corp
CELG
$824K 0.19%
10,371
+811
+8% +$67.3K
TRIL
136
DELISTED
Trillium Therapeutics Inc.
TRIL
$823K 0.18%
137,091
+28,907
+27% +$184K
CMCSA icon
137
Comcast
CMCSA
$85.3B
$817K 0.18%
24,915
-984
-4% -$32.1K
DCI icon
138
Donaldson
DCI
$10.4B
$797K 0.18%
17,664
+1,941
+12% +$89.6K
UPS icon
139
United Parcel Service
UPS
$96.2B
$789K 0.18%
7,427
+496
+7% +$55.7K
ESNT icon
140
Essent Group
ESNT
$6.11B
$788K 0.18%
22,004
+2,406
+12% +$87.1K
ALDX icon
141
Aldeyra Therapeutics
ALDX
$104M
$786K 0.18%
98,892
+34,863
+54% +$278K
CB icon
142
Chubb
CB
$137B
$784K 0.18%
6,175
+337
+6% +$44.8K
GPK icon
143
Graphic Packaging
GPK
$3.22B
$783K 0.18%
53,960
+7,192
+15% +$107K
IEFA icon
144
iShares Core MSCI EAFE ETF
IEFA
$185B
$774K 0.17%
12,216
+614
+5% +$40.6K
VSEC icon
145
VSE Corp
VSEC
$5.46B
$771K 0.17%
16,139
+2,197
+16% +$110K
ECL icon
146
Ecolab
ECL
$75.6B
$753K 0.17%
5,364
+815
+18% +$118K
BRSS
147
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$742K 0.17%
23,676
+3,532
+18% +$113K
WY icon
148
Weyerhaeuser
WY
$17.2B
$733K 0.16%
20,113
+5
+0% +$183
FONR
149
DELISTED
Fonar
FONR
$726K 0.16%
27,341
+3,789
+16% +$106K
LKFT
150
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.9B
$720K 0.16%
+7,810
New +$758K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q2 2018 Portfolio in Review

As of Q2 2018, Stanley-Laman Group held 285 positions worth $445M, up 1.4% from $439M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q2 2018 filing shows 23 new, 106 increased, 62 reduced and 22 closed positions. Its largest new stake was Honeywell: 21,094 shares worth $2.75M. The largest sale was KapStone Paper and Pack Corp., an estimated $4.63M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • Stanley-Laman Group's largest Q2 2018 buy was Honeywell: 21,094 shares worth $2.75M.
  • Stanley-Laman Group added most to Neurocrine Biosciences in Q2 2018, an estimated $960K increase.
  • Stanley-Laman Group's biggest Q2 2018 reduction was Qualys, cutting an estimated $1.16M.
  • Stanley-Laman Group fully exited KapStone Paper and Pack Corp. in Q2 2018, selling an estimated $4.63M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $445M portfolio in Q2 2018.
  • Stanley-Laman Group opened 23 new positions and closed 22 in Q2 2018.
  • Stanley-Laman Group's portfolio value rose 1.4% quarter-over-quarter to $445M.

Based on Stanley-Laman Group's 13F filing for Q2 2018, filed 9 Aug 2018.